Cargando…

Can biomarkers be used to predict bronchopulmonary dysplasia?()

Detalles Bibliográficos
Autores principales:	Bhandari, Vineet, Sahni, Mitali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432051/ https://www.ncbi.nlm.nih.gov/pubmed/33183652 http://dx.doi.org/10.1016/j.jped.2020.10.001

Ejemplares similares

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Recent advances in understanding and management of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2020)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia
por: Lal, Charitharth Vivek, et al.
Publicado: (2018)

Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia
por: Balany, Jherna, et al.
Publicado: (2015)

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

Non-Invasive Ventilatory Strategies to Decrease Bronchopulmonary Dysplasia—Where Are We in 2021?
por: Dumpa, Vikramaditya, et al.
Publicado: (2021)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

The Wnt Signaling Pathway and the Development of Bronchopulmonary Dysplasia
por: Lingappan, Krithika, et al.
Publicado: (2020)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta?
por: Thébaud, Bernard
Publicado: (2021)

Leveraging Microbial Symbiosis to Modulate Bronchopulmonary Dysplasia
por: Peterson, Laura S., et al.
Publicado: (2022)

How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”
por: Nelin, Leif D., et al.
Publicado: (2017)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
por: Das, Pragnya, et al.
Publicado: (2018)

Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
por: Alvarez-Fuente, Maria, et al.
Publicado: (2019)

Early prediction of bronchopulmonary dysplasia: can noninvasive monitoring methods be essential?
por: Cui, Xuewei, et al.
Publicado: (2023)

Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Sheth, Sudip, et al.
Publicado: (2019)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

Lung function in adults born prematurely with bronchopulmonary dysplasia
por: Chen, I-Ling, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: A Continuum of Lung Disease from the Fetus to the Adult
por: Jobe, Alan H., et al.
Publicado: (2019)

Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
por: Balena-Borneman, Jessica, et al.
Publicado: (2016)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Bronchopulmonary dysplasia predicted at birth by artificial intelligence
por: Verder, Henrik, et al.
Publicado: (2020)

Prediction Model for Bronchopulmonary Dysplasia in Preterm Newborns
por: Jassem-Bobowicz, Joanna Maria, et al.
Publicado: (2021)

Bronchopulmonary dysplasia: how can we improve its outcomes?
por: Sung, Tae-Jung
Publicado: (2019)

New Imaging Tools Allow Bronchopulmonary Dysplasia to Enter the Age of Precision Medicine
por: Shepherd, Edward G., et al.
Publicado: (2020)

rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention?
por: Plosa, Erin J., et al.
Publicado: (2020)

Mesenchymal Cells and Bronchopulmonary Dysplasia: New Insights about the Dark Side of Oxygen
por: Popova, Antonia P.
Publicado: (2019)

Intermittent Hypoxemia and Bronchopulmonary Dysplasia: Manifestations of Immature Respiratory Control and the Preterm Lung
por: Di Fiore, Juliann M., et al.
Publicado: (2021)

Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2021)

Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
por: Kindt, Alida S. D., et al.
Publicado: (2022)

Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age
por: Lodha, Abhay, et al.
Publicado: (2014)

Urinary biomarkers for the early prediction of bronchopulmonary dysplasia in preterm infants: A pilot study
por: Cui, Xuewei, et al.
Publicado: (2022)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5e37441krrtuu19crf547fraf6